Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Do antisense oligonucleotides improve viral immunopathology?].

S Wasmuth1, D Bauer, K P Steuhl

  • 1Ophtha-Lab und Augenabteilung, St. Franziskus Hospital, Münster.

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|September 2, 2004
PubMed
Summary

Antisense oligonucleotides (ASON) targeting tumor necrosis factor-alpha (TNF-alpha) effectively reduced inflammation in experimental herpes simplex virus-1 keratitis (HSK). Local ASON administration suppressed disease development in vivo, showing therapeutic potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Constraint on Atmospheric Millicharged Particles with the LUX-ZEPLIN Experiment.

Physical review letters·2025
Same author

Dark Matter Search Results from 4.2  Tonne-Years of Exposure of the LUX-ZEPLIN (LZ) Experiment.

Physical review letters·2025
Same author

First Dark Matter Search Results from the LUX-ZEPLIN (LZ) Experiment.

Physical review letters·2023
Same author

Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy.

Journal of virus eradication·2023
Same author

GlyT1 encephalopathy: Characterization of presumably disease causing GlyT1 mutations.

Neurochemistry international·2020
Same author

Heteroresistant Bacteria Detected by an Extended Raman-Based Antibiotic Susceptibility Test.

Analytical chemistry·2020

Area of Science:

  • Ophthalmology
  • Immunology
  • Virology

Background:

  • Tumor necrosis factor-alpha (TNF-alpha) is a key proinflammatory cytokine in herpes simplex virus-1 keratitis (HSK).
  • Investigating local administration of antisense oligonucleotides (ASON) targeting TNF-alpha for HSK amelioration.

Purpose of the Study:

  • To evaluate the efficacy of ASON targeting TNF-alpha in treating experimental HSK.
  • To assess the in vitro and in vivo effects of ASON on TNF-alpha production and HSK development.

Main Methods:

  • In vitro studies utilized fluorescence microscopy and flow cytometry to assess ASON uptake and efficacy.
  • In vivo studies employed an animal model of HSK to scrutinize substance- and sequence-specific influences of ASON.
  • Corneal subepithelial injections of ASON were administered.

Related Experiment Videos

Main Results:

  • FITC-labeled ASON demonstrated quick and stable uptake by immune cells in vitro.
  • ASON addition significantly downregulated TNF-alpha production by stimulated cells.
  • Subepithelial corneal injection of ASON targeting TNF-alpha ameliorated HSK incidence and development in vivo.
  • Control oligonucleotides and buffer showed no significant effect on HSK.

Conclusions:

  • ASON effectively reduced TNF-alpha secretion in vitro.
  • Local administration of ASON targeting TNF-alpha suppressed experimental HSK development in vivo.